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Abstract
Background: Combining outcomes and the use of standardized effect measures such as effect size
and standardized response mean across instruments allows more comprehensive meta-analyses
and should avoid selection bias. However, such analysis ideally requires that the instruments
correlate strongly and that the underlying assumption of similar responsiveness is fulfilled. The aim
of the study was to assess the correlation between two widely used health-related quality of life
instruments for patients with chronic obstructive pulmonary disease and to compare the
instruments' responsiveness on a study level.
Methods:  We systematically identified all longitudinal studies that used both the Chronic
Respiratory Questionnaire (CRQ) and the St. George's Respiratory Questionnaire (SGRQ)
through electronic searches of MEDLINE, EMBASE, CENTRAL and PubMed. We assessed the
correlation between CRQ (scale 1 – 7) and SGRQ (scale 1 – 100) change scores and compared
responsiveness of the two instruments by comparing standardized response means (change scores
divided by their standard deviation).
Results: We identified 15 studies with 23 patient groups. CRQ change scores ranged from -0.19
to 1.87 (median 0.35, IQR 0.14–0.68) and from -16.00 to 3.00 (median -3.00, IQR -4.73–0.25) for
SGRQ change scores. The correlation between CRQ and SGRQ change scores was 0.88.
Standardized response means of the CRQ (median 0.51, IQR 0.19–0.98) were significantly higher
(p < 0.001) than for the SGRQ (median 0.26, IQR -0.03–0.40).
Conclusion: Investigators should be cautious about pooling the results from different instruments
in meta-analysis even if they appear to measure similar constructs. Despite high correlation in
changes scores, responsiveness of instruments may differ substantially and could lead to important
between-study heterogeneity and biased meta-analyses.
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Background
Systematic reviews and meta-analyses should include all
available evidence to avoid selection bias and to increase
the power of analyses of primary effects and effect modi-
fication by differences in patients and interventions. In
meta-analysis of patient reported outcome (PRO) meas-
ures, effects are, however, often measured with different
instruments. For example, meta-analyses of respiratory
rehabilitation in chronic obstructive pulmonary disease
(COPD) are typically either based on studies using the
Chronic Respiratory Questionnaire (CRQ)[1] or the St
George's Respiratory Questionnaire (SGRQ) [2-4].
Investigators often deal with this challenge by standardiz-
ing scores from different instruments and combining
them as unit-free scores – effect sizes or standardized
response means (SRMs)[2,5,6] However, critics have
noted that, because standard deviations (SD) may vary
substantially from study to study, treatment effects that
are homogeneous when expressed in their original unit
can become heterogeneous when expressed as (SRM) [7].
An alternative to standardisation is to directly transform
PRO scores. For instance, investigators could transform
CRQ into SGRQ scores or vice versa using transformation
coefficients from regression analyses [8].
For either method of combining scores, two important
premises must ideally be met. First, the scores must corre-
late strongly indicating that the instruments measure con-
structs that are similar enough to be combined. Second,
the responsiveness – the instrument's ability to detect
important changes even if those changes are small –
should be similar. If instruments express different magni-
tude of change for identical underlying effects, less
responsive instruments will underestimate treatment
effects, and meta-analyses will manifest heterogeneity that
might falsely be attributed to variability in patient or
interventions or effects of the interventions.
While investigators found moderate to strong correlations
between the CRQ and SGRQ on an individual patient
level [9-12] suggesting that they provide similar informa-
tion, it is unknown whether a strong relationship between
CRQ and SGRQ change scores exists on a study level. The
objective of this study was to assess the correlation of CRQ
and SGRQ change scores as well as their responsiveness
on a study level and to evaluate the implications for com-
bining scores in meta-analyses.
Methods
We conducted a systematic literature search to identify all
longitudinal studies that used both the CRQ and SGRQ.
Search strategy
We began the literature search by identifying all studies
that used the CRQ using the keywords "chronic respira-
tory questionnaire", "chronic respiratory disease ques-
tionnaire", "CRQ" and "CRDQ" for electronic database
searches in MEDLINE (Ovid version, New York, New
York, from inception to November 2004), EMBASE
(DataStar version, Cary, North Carolina from inception to
November 2004) and the Cochrane Central Register of
Controlled Trials (Oxford, United Kingdom, 2004, Issue
4). We also used the related articles feature in PubMed
(National Library of Medicine, Washington, Maryland)
for included articles to search for additional papers. In
addition, we hand-searched the bibliographies of
included primary studies and our own files.
Study selection criteria
Study design
Eligible studies included both randomized controlled tri-
als and uncontrolled studies with a baseline measurement
and at least one follow-up measurement of the CRQ and
SGRQ.
Participants
We included studies if more than 90% of study partici-
pants had COPD defined by chronic airflow obstruction
(FEV1 less than 80% predicted) and little reversibility of
airflow obstruction (reversibility of FEV1 in % predicted
in response to inhaled β-agonists below 20%).
Interventions
Any intervention, usual care, placebo or time (natural his-
tory).
Outcome measures
Studies had to include both the CRQ and SGRQ.
Study selection
Two members of the study team independently scruti-
nized the titles and abstracts of all identified citations (see
Figure 1). We obtained the full text of any article that was
deemed potentially eligible by one of the reviewers. The
two reviewers then evaluated the full text of all retrieved
papers and evaluated their eligibility, resolving disagree-
ment by consensus.
Data extraction
Information extracted included details about patients,
interventions, length of follow-up, study design, mean
change scores (difference between follow-up scores and
baseline) for the CRQ total and SGRQ total scores, and SD
of CRQ total and SGRQ total baseline and change scores.
If the SD was not available from reports we used the
median SD from studies that reported the SD. For studies,
for which a CRQ total score was not provided in the arti-Health and Quality of Life Outcomes 2006, 4:94 http://www.hqlo.com/content/4/1/94
Page 3 of 8
(page number not for citation purposes)
Study flow from electronic database searches to final inclusion of eligible studies Figure 1
Study flow from electronic database searches to final inclusion of eligible studies.
Total citations identified from electronic databases (Medline, Embase, 
CENTRAL)
n=538
All studies included n=15
Excluded after full text assessment
Reasons for exclusion:
- Review article n=7
- Only CRQ n=6 
- CRQ and SGRQ not in all patients n=1 
- Other reasons n=2
Total: n=16
Citations excluded after screening titles
and abstracts
n=511
Studies retrieved for detailed evaluation:
- From electronic databases: n=27
- From hand searching (conference proceedings, reference lists of
reviews and identified studies, Science Citation Index and “related
articles” function of PubMed entering identified studies) : n=4
Total: n=31
Initial agreement on in-
and exclusion:
94%, N=0.87Health and Quality of Life Outcomes 2006, 4:94 http://www.hqlo.com/content/4/1/94
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cle, we calculated the mean of the four domain change
scores. Because one cannot calculate SGRQ total scores on
the basis of domain scores, we asked authors of articles
reporting only SGRQ domain scores to provide total
scores.
Quality assessment
We evaluated two aspects of study quality. First, we
assessed whether the order of administration of the CRQ
and SGRQ was randomised and second, whether investi-
gators used validated versions of the CRQ and SGRQ. We
considered questionnaires to be validated if the investiga-
tors referred to a reference for the validation process in the
respective language.
Statistical analysis
We performed all analyses on a study level. We first calcu-
lated median CRQ and SGRQ scores together with their
interquartile ranges (25th  to 75th  percentile). We then
assessed the relationship between CRQ and SGRQ change
scores using scatter plots and Spearman rank correlation
coefficients. Our criterion for a strong correlation, 0.7 or
more, exceeded that of previous studies with individual
patient data (0.5) because the use of mean change scores
is likely to increase correlation coefficients by lowering
denominators of the correlation coefficients.
To compare the responsiveness of the CRQ and SGRQ we
calculated SRMs by dividing change scores by the SD of
change cores and multiplying the resulting SGRQ SRM by
-1 to adjust for the fact that negative scores indicate
improvement on the SGRQ [13]. We then conducted a
Wilcoxon signed-rank test. We performed all statistical
analyses using SPSS for Windows version 12.0.1 (SPSS
Inc, Chicago, Ill).
Results
The electronic database search yielded 538 citations of
which 27 articles were potentially eligible (Figure 1); hand
searching added another 4 articles. Full text review of
these 31 articles demonstrated that 15 studies fulfilled our
inclusion criteria. Most of the 16 excluded studies were
review articles or included only the CRQ. Agreement on
inclusion and exclusion was excellent (agreement in 94%
of all decisions, chance-corrected kappa = 0.87).
Table 1 describes the 15 included studies that reported on
22 patient groups. In 11 groups, patients followed a respi-
ratory rehabilitation program; 9 groups were cohorts
without specific interventions or controls in randomized
controlled trials receiving usual care, patient education or
placebo and in two groups, patients received inhaled
bronchodilators. Sample size ranged from 21 to 183 and
duration of follow-up from 4 to 52 weeks. In all studies,
investigators used validated versions of the CRQ and
SGRQ and in four studies they randomized the order of
administration of the CRQ and SGRQ. The results pub-
lished by Bestall [14] and Wedzicha [15] were based on
the same randomized controlled trial. We only included
the last available data for each patient group, i.e. the 52
weeks follow up data for patients with moderate to severe
COPD and the 8-week follow-up data for patients with
severe COPD. For one study, mean CRQ and SGRQ total
change scores were not available [16].
Mean total scores at baseline ranged from 2.64 to 5.31 for
the CRQ and from 40.3 to 69.6 for the SGRQ. The corre-
lation coefficient for total scores at baseline was -0.86
(95% CI 0.62–1.00).
CRQ change scores ranged from -0.19 to 1.87 (median
0.35, IQR 0.14–0.68) and for the SGRQ from -16.10 to
3.00 (median -3.00, IQR -4.73–0.25). Figure 2 shows the
strong correlation between CRQ and SGRQ change scores
with a correlation coefficient of 0.88. One study [17]
showed substantially larger effects than the others on both
instruments and could have led to this strong correlation.
However, a sensitivity analysis excluding the study by
Man et al [17] showed that it had little influence on the
correlation coefficient (r = 0.86).
Figure 3 shows the SRMs for the CRQ and SGRQ. SRMs
ranged from -0.24 to 3.53 for the CRQ (median 0.51, IQR
0.19–0.98) and were significantly higher (p < 0.001) com-
pared to standardised response means of the SGRQ (range
from -0.29 to 2.71, median 0.26, IQR -0.03–0.40).
Discussion
We observed that high correlation between PRO measure
change scores does not necessarily imply similar respon-
siveness. In our example of the CRQ and SGRQ we
showed a strong correlation between total change scores
on a study level, but the CRQ was substantially more
responsive than the SGRQ. This finding indicates that
these two measures provide very similar information and
could justify the use of pooled estimates in meta-analyses
on a conceptual, theoretical level. However, studies using
the less responsive measure are likely to underestimate
treatment effects and to introduce heterogeneity in study
results.
Strengths of this study include the systematic review
approach to identifying longitudinal studies using both
the CRQ and SGRQ. A limitation of our approach is the
lack of individual patient data to explore the association
between CRQ and SGRQ change scores in greater detail.
Earlier studies indicated that the responsiveness of the
CRQ is superior to the SGRQ when applied to the same
patients [12,13]. Our results extend these findings beyondH
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Table 1: Characteristics of included studies
Study groups Number of 
patients
Intervention Wks of 
follow-up
Study design Mean baseline scores (SD) Mean change scores (SD) Order of 
questionnaires 
randomized
Use of validated 
questionnaires
CRQ SGRQ CRQ SGRQ
Barr [18] 102 Respiratory rehabilitation (RP) 4 Prospective follow-up study 3.89 (0.89) 55.8 (17.9) 0.71 (0.75) -3.00 (12.20) No Yes
Bestall [14] 23 RP 52 RCT 4.00 (0.90) 51.0 (13.7) 0.35 (0.85) -3.00 (12.20) No Yes
Bestall [14] 21 Patient education 52 RCT 4.28 (0.98) 51.9 (13.9) -0.05 (0.58) -1.00 (9.35) No Yes
Bourbeau [22] 65 RP 2 Prospective follow-up study n.a. n.a. 0.74 (0.74) -7.20 (12.30) Yes Yes
Bourbeau [22] 27 Usual care 2 Prospective follow-up study n.a. n.a. 0.35 (0.31) -2.40 (5.57) Yes Yes
Connor [16] 170 RP 52 Prospective follow-up study n.a. 51.6 (15.8) n.a. n.a. No Yes
Desikan [23] 40 Usual care 12 Prospective follow-up study 3.75 (0.95) 50.2 (18.5) 0.33 (0.86) -2.51 (9.71) Yes Yes
de Torres [19] 37 RP 8 Prospective follow-up study 4.13 (0.95) 52.0 (13.0) 0.56 (1.20) -4.00 (13.40) No Yes
Griffiths [20] 37 RP 52 RCT 3.59 (0.95) 64.9 (12.7) 0.25 (0.80) -3.40 10.86) No Yes
Griffiths [20] 33 Usual care 52 RCT 3.53 (0.95) 68.3 (13.3) -0.08 (0.80) 0.70 (10.86) No Yes
Hajiro [24] 165 Usual care 12 Prospective follow-up study 5.31 (0.97) 40.3 (20.1) 0.65 (0.83) -6.00 (18.50) No Yes
Harper [25] 156 Usual care 26 Prospective follow-up study 3.69 (0.95) 65.4 (15.9) 0.07 (1.00) 0.81 (9.95) No Yes
Man [17] 21 RP 18 RCT 2.64 (0.95) 65.4 (13.5) 1.87 (0.53) -16.10 (5.95) No Yes
Man [17] 21 Usual care 16 RCT 3.11 (0.95) 69.6 (13.6) 0.49 (0.26) -3.40 (8.50) No Yes
Rutten [9] 47 Salmeterol + Ipratropium 12 RCT 4.44 (0.81) 48.3 (13.9) 0.20 (0.60) -2.40 (11.00) No Yes
Rutten [9] 47 Salmeterol + Placebo 12 RCT 4.58 (1.03) 50.5 (16.6) -0.19 (0.80) -0.01 (7.10) No Yes
Rutten [9] 50 Placebo 12 RCT 4.22 (1.05) 50.2 (15.8) 0.03 (0.70) 0.50 (9.20) No Yes
Singh [12] 97 RP 7 Prospective follow-up study 3.66 (0.92) 58.8 (15.2) 0.72 (1.00) -4.02 (12.98) No Yes
Schunemann [8] 84 RP 12 Prospective follow-up study 4.01 (0.95) 52.8 (13.9) 1.14 (0.90) -8.10 (20.40) Yes Yes
Schunemann [10] 183 RP 12 Prospective follow-up study 4.57 (0.95) 50.6 (13.9) 0.55 (0.89) -5.43 (11.18) Yes Yes
Wedzicha [15] 26 RP on 8 RCT 3.76 (0.90) 56.7 (14.0) 0.20 (0.39) 3.00 (10.40) No Yes
Wedzicha [15] 28 Patient education 8 RCT 3.82 (1.20) 59.1 (13.0) 0.20 (0.32) 2.00 (8.10) No Yes
RCT: Randomized controlled trial; n.a.: not availableHealth and Quality of Life Outcomes 2006, 4:94 http://www.hqlo.com/content/4/1/94
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the previous samples and demonstrate its generalizability.
The phenomenon will not only lead to underestimates of
effect in studies using the SGRQ, but could lead investiga-
tors who are unaware of different responsiveness to spuri-
ously attribute variability to differences in patients,
interventions, intervention effects or methodological
quality.
The rehabilitation studies included in this systematic
review indicate the extent of underestimation by the
SGRQ. In the nine studies with patients following respira-
tory rehabilitation[8,10,12,14,15,17-20], the median
SGRQ change was 4.0 points or, expressed as SRM 0.31.
The corresponding SRM based on the CRQ change scores
was 0.62. If the SRM of 0.62 was expressed as SGRQ
change scores the corresponding change would be 8.0
points. The difference of 4 points between changes meas-
ured by the CRQ and SGRQ is substantial and equivalent
to the minimal important difference of the SGRQ or to the
shift from a minimal to a moderate difference [8].
A conservative solution to the problem with meta-analysis
that we raised is to restrict analyses to the most responsive
available instrument. Investigators could develop alterna-
tives allowing for combining trials with different instru-
ments. Preferable alternatives to this conservative
approach would include testing for an association
between effect size and the outcome measure and, if there
is no association within the individual meta-analysis,
using all studies irrespective of outcome measure. Alterna-
tively, investigators could introduce instrument as a varia-
ble in meta-regression models. Finally, if there is a strong
linear relationship between instruments (as in this case),
one could transform the scores of one instrument into
those of another instrument. For example, SGRQ scores
could be transformed into CRQ scores using the equation
of a linear regression model where SGRQ was used to pre-
dict CRQ scores[8]
In theory, reasons for the superior responsiveness of the
CRQ could include statistical reasons, differences in the
aspects of HRQL measured by the CRQ and SGRQ, and
the way these questionnaires are administered. A statisti-
cal reason why the CRQ is more responsive is the lower
variability of CRQ scores leading to smaller noise terms.
The domains of CRQ and SGRQ do not measure identical
aspects of HRQL even though their total scores correlate
highly. The domains of SGRQ focus on impairment from
respiratory symptoms while the CRQ also addresses
impairment from extra-pulmonary manifestations of
COPD such as fatigue or depressive symptoms. Thereby, it
is possible that the CRQ captures, by its broader approach,
improvements of pulmonary and extra-pulmonary mani-
festation better than the SGRQ. However, the correspond-
ing domains on the two questionnaires (e.g. symptoms
and impact on the SGRQ compared with dyspnea and
physical functioning) generally show greater responsive-
ness for the CRQ indicating that this may not be the expla-
nation. Finally, the administration format may also
influence responsiveness. In two randomised trials where
Box plots showing the distributions of standardised response  means for the CRQ and SGRQ Figure 3
Box plots showing the distributions of standardised response 
means for the CRQ and SGRQ. Boxes display the interquar-
tile range and the median while the whiskers show 95% of 
the data. Asterisks indicate an outlier study group [17] that 
showed much larger change scores that the other studies.
Chronic Respiratory 
Questionnaire
-1.0
0.0
1.0
2.0
3.0
/
/
St. Georges 
Respiratory
Questionnaire
Standardised
response mean
Scatter plots of CRQ and SGRQ change scores from 21  groups where patients completed both the CRQ and SGRQ Figure 2
Scatter plots of CRQ and SGRQ change scores from 21 
groups where patients completed both the CRQ and SGRQ.
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change score
Chronic Respiratory Questionnaire
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we compared the interviewer- and self-administered
CRQ[10,11] we found that the self-administered CRQ
tends to be more responsive than the interviewer-admin-
istered CRQ. This was mainly due to lower baseline scores
with the self-administered format. Patients may be more
willing to express the severity of impairment in the
absence of an interviewer. Thus self-administration might
enhance responsiveness compared with interviewer-
administration. The SGRQ is a self-administered ques-
tionnaire and the CRQ required, until recently and as it
was the case in the studies of this systematic review, an
interviewer. If self-administration is associated with
greater responsiveness the analyses presented in this arti-
cle may even underestimate differences in responsiveness
between the CRQ and the SGRQ.
Conclusion
The presence of a strong relationship of two different
instruments alone does not allow combining them in
meta-analysis. There should be similar responsiveness,
otherwise pooled estimates may become biased and sub-
stantial heterogeneity can arise. At present, investigators
should remain cautious about combining results from tri-
als that use different instruments without careful explora-
tion of possible heterogeneity of the results.
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